Gabapentin Synthesis via Dilute Acid Decarboxylation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The existing processes for preparing Gabapentin and its intermediate 1,1-cyclohexane diacetic acid monoamide (CDMA) are cumbersome and environmentally hazardous due to the use of concentrated sulfuric acid, leading to foaming issues and low yields, making them unsuitable for industrial-scale, cost-effective production.

Innovation Solution

A novel process that decarboxylates diimide VI under alkaline conditions to produce CDMA directly, avoiding the need for intermediate cyclohexane diacetic acid and using dilute sulfuric acid, which eliminates foaming and increases yields, allowing for a more efficient and environmentally friendly synthesis of Gabapentin.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Temperature

If concentrated sulfuric acid is used for decarboxylation of dinitrile, then the reaction proceeds at high temperature, but copious carbon dioxide is liberated causing severe foaming

Engineering Contradiction:
Improvereaction temperatureVSAvoidfoaming
Core Design Contradiction:
TemperatureVSObject-generated harmful factors

Solution Approach 1:

The patent inverts the conventional approach by using dilute sulfuric acid (5-20%) instead of concentrated sulfuric acid (95.6%) for the decarboxylation reaction. This reversal of acid concentration eliminates the severe foaming problem that occurs with concentrated acid while still achieving effective decarboxylation of the dinitrile to produce CDA.

Inventive Principle:
Principle #13The other way round (Inversion)

Solution Approach 2:

The patent changes the parameter of acid concentration from high (95.6%) to low (5-20%), which fundamentally alters the reaction behavior. This parameter change reduces the violent carbon dioxide evolution that causes foaming, while maintaining reaction effectiveness through extended reaction time and controlled heating.

Inventive Principle:
Principle #35Parameter changes

2Productivity

If concentrated sulfuric acid is used for decarboxylation, then the reaction is fast, but the process is environmentally hazardous and cumbersome

Engineering Contradiction:
Improvereaction rateVSAvoidenvironmental hazard
Core Design Contradiction:
ProductivityVSObject-affected harmful factors

Solution Approach 1:

The patent changes the acid concentration parameter to dilute ranges (5-20%), which makes the process environmentally safer and easier to handle while still achieving productive results through optimized reaction conditions including extended time and controlled temperature profiles.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent converts the potential harm of slow reaction rate with dilute acid into a benefit by allowing controlled, safe reaction progression. The slower but manageable reaction rate with dilute acid enables better heat control and eliminates the hazards associated with concentrated acid handling, making the process industrially viable.

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

3Manufacturing precision

If conventional multi-step process is used to prepare CDMA from dinitrile, then intermediate CDA can be isolated, but the process is cumbersome and requires multiple steps

Engineering Contradiction:
Improveintermediate isolationVSAvoidprocess complexity
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The patent merges the decarboxylation step and the subsequent conversion to CDMA into a single integrated process using dilute sulfuric acid. This combination eliminates the need for separate isolation and purification steps for intermediate CDA, reducing process complexity while maintaining product quality.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The patent establishes continuous useful action by performing decarboxylation and CDMA formation in one continuous process without interrupting for isolation steps. The reaction proceeds continuously from dinitrile through CDA formation to final CDMA product, improving manufacturing efficiency.

Inventive Principle:
Principle #20Continuity of useful action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This process achieves higher yields and purity of CDMA and Gabapentin, is free from foaming issues, and is more economical, making it suitable for industrial-scale production while being environmentally benign.

Implementation Method 1

decarboxylation of diimide VI was explored under alkaline conditions... the foaming problem is result of decarboxylation reaction under acidic conditions, it was envisaged that the foaming problem could be avoided by carrying out the reaction under alkaline conditions

Methodology Applied
Scientific EffectDecarboxylation:

Implementation Method 2

hydrolysis of diimide VI under alkaline conditions resulted in CDMA(IV)

Methodology Applied
Scientific EffectHydrolysis: Hydrolysis

Data Source

PatentEP3604272B1Process for the preparation of gabapentin
Publication Date: 2021.04.14 DIVI S LAB LTD
  • EP3604272B1 patent drawing
  • EP3604272B1 patent drawing
  • EP3604272B1 patent drawing

AI summary

The present invention relates to an improved process for the preparation of Gabapentin. The process also relates to a new process for the preparation of 1, 1-cyclohexane diacetic acid monoamide (CDMA), which is a key intermediate for the preparation of Gabapentin.